Section

Science & Medicine

Peer-reviewed research, FDA approvals, psychedelics, neuromodulation, genetics.

Dispensary Weed Is a Different Drug Than the One D.A.R.E. Warned You About

Legal cannabis today routinely tops 40% THC — quadruple the average street potency of 1995 — and almost nobody selling it is required to tell you what that means for your brain.

Dispensary THC now routinely exceeds 40%, quadruple 1995 levels. The addiction and psychosis science on high-potency cannabis is real, dose-dependent, and almost nobody at the counter has to mention it.

Sep 127 minRead

More in Science & Medicine

191 total in this section

02Science & MedicineSep 11

The Overdose Charts Miss This: A Decade of Data Says a Third of Alcohol-Induced Crises Come With Depression Attached

A decade of federal treatment data finds alcohol- and substance-induced psychiatric disorders are rare in raw numbers but frequently paired with depression — a screening gap most facilities aren't built to catch.

03Science & MedicineSep 11

Every Two Years, the Fake Xanax Gets a New Name. The Real Trend Is the Naming Pattern Itself.

Bromazolam is the fourth designer benzodiazepine sold as counterfeit Xanax since 2020. The DEA keeps scheduling the newest one — the trend data says that's not where the problem lives.

04Science & MedicineSep 10

Your First Ambien Prescription Predicts Whether You're Still Taking It in Seven Years

A JAMA Network Open study of 129,287 patients found that the length of a person's first Z-drug prescription — not their diagnosis, not their age — is the strongest predictor of whether they're still refilling it seven years later.

05Science & Medicine

Earlier in Science & Medicine

Every piece in this section, most recent first.

Science & Medicine

Dispensary Weed Is a Different Drug Than the One D.A.R.E. Warned You About

More in Science & Medicine

The Overdose Charts Miss This: A Decade of Data Says a Third of Alcohol-Induced Crises Come With Depression Attached

Every Two Years, the Fake Xanax Gets a New Name. The Real Trend Is the Naming Pattern Itself.

Your First Ambien Prescription Predicts Whether You're Still Taking It in Seven Years

There's No Suboxone for Meth. The Reason Is in the Chemistry, Not the Funding.

Your Craving Isn't Just a Feeling. Yale Says It's Rewiring How You Decide, in Real Time.

The FDA Finally Wrote Rules for Psychedelic Trials. Now It Wants to Hear If They're Any Good.

Earlier in Science & Medicine

Relapse Isn't a Willpower Failure. Two New Studies Say It's Math the Brain Never Stopped Running.

The FDA Is Finally Asking the Public What It Thinks About Psychedelic Therapy. That Question Was Illegal to Even Study for 40 Years.

Ketamine Works Because It Unmoors You From Yourself — And Almost Nobody Is Watching How It's Sold

Banning Xylazine Didn't Shrink the Tranquilizer Supply. It Just Renamed the Problem Medetomidine.

The Same Drug Class Behind Ozempic Is Now the Most Promising Alcohol Medication in 20 Years

The Cannabis Red Flag Isn't How Often. It's How Many Ways.

The Feds Are Scheduling Three New Drugs at Once. The Chemists Are Already on a Fourth.

Psilocybin Just Got the FDA's Fastest Lane Ever Built. Getting There Is Still the Hard Part.

A Brain Region Lights Up Before Relapse Happens, Mouse Study Suggests

MDMA Therapy's Second Shot at FDA Approval Skips the One Thing That Sank It Last Time

The Wine Study Measured Wealth, Not Wine

American Drinking Just Hit a Historic Low — Because the 'Healthy Glass of Wine' Myth Finally Died

Cannabis Use Disorder Just Passed Alcohol in America — and Emergency Rooms Are Already Catching the Bill

Alcohol Use Disorder Is Finally Falling. Cannabis Use Disorder Is Climbing to Take Its Place.

Oregon Has Run the Largest Real-World Psilocybin Experiment on Earth. The First Full Results Are In.

Cannabis Didn't Get Safer Than Alcohol — the Evidence Against It Just Got Sharper

The Psilocybin Lab Left the Building — Two New Studies Show What Happens Next

Semaglutide Just Outperformed Every FDA-Approved Alcohol Medication. It's Still Not Approved For That.

A Brain Scan Just Showed What Mindfulness Actually Does to a Craving

The VA Just Bet on Ozempic for Alcoholism — Because No One Ever Built Alcoholism a Drug of Its Own

Ketamine Is Becoming Medicine and Contraband at the Same Time

The Math on Cutting Syringe Funding: Up to 39,600 Extra Deaths

FDA Fast-Tracks an Ozempic-Class Drug for Alcohol Use Disorder

A Fentanyl Vaccine Is in Human Trials. It Is Not Ready to Save Anyone Yet.

Your Brain Doesn't Just Feel a Craving. A Craving Changes How Your Brain Decides.

The Starting Dose Your Doctor Writes for Anxiety Is Already in the Danger Zone

A New 340,000-Person Drinking Study Will Get Misquoted by Friday. Here's What It Actually Found.

The FDA Just Cut Psilocybin's Review to Two Months — and the Drug Was Never the Slow Part

Scheduling Xylazine Didn't Make It Disappear. It Made Room for Something Worse.

Psilocybin's FDA Clock Just Started Ticking — the DEA's Hasn't

People Who Drink and Occasionally Use Psilocybin Score Lower on Depression Scales. Don't Call It a Treatment Yet.

How Ibogaine Went From a Schedule I Ghost Story to a Trump Executive Order in One Spring

Ketamine Isn't Just Rewiring Your Mood. It's Quietly Eating Your Bladder From the Inside.

One Dose of Psilocybin Beat Cocaine Craving for Six Months. The Placebo Group Knew Within an Hour Which Pill They'd Gotten.

Ozempic Wasn't Built for Alcohol Use Disorder. New Data Says It's Helping Anyway.

89 Drugs Went Up Against Cocaine Addiction. None of Them Won.

A Weight-Loss Drug Is Beating Alcoholism's Two Boring Pills, and the VA Just Bet On It

The Craving Will Pass Either Way. New Research Says Your Breath Can Make the Passing Easier

Twelve Veterans Had Already Failed Every PTSD Treatment. Nine Are in Remission After Two Doses of Psilocybin.

The Ozempic-for-Drinking Trial Just Published Real Numbers. The Headline Effect Missed Its Own Primary Target.

45 Million Americans Have a Substance Use Disorder Right Now. The Government's Own Survey Says So — and Says Most Won't Get Treated.

Nicotine Pouches Didn't Slip Past Public Health. They Got Rebranded as Self-Optimization

A Major New Review Found Cannabis Doesn't Curb Cocaine Cravings — It Intensifies Them

Stop Treating the Trip as a Side Effect

Xylazine Went National While the Dose Went Down. Don't Call That Good News.

A Fentanyl Vaccine Just Reached Human Testing. Here's What It Can't Do.

One Dose of Cocaine Rewrites How a Brain Cell's DNA Is Folded. That Word 'Recreational' Just Got Harder to Use.

The FDA Finally Wrote Down How to Blind a Trial When the Drug Makes You Trip

Daily Cannabis Use Raises Psychosis Risk. It Still Won't Fix Your Anxiety.

A Teenager Asked for Cannabis Treatment. A New Study Says the Wait Got Worse, Not Better.

Craving Doesn't Wait for You to Decide. It Changes the Math First.

Stimulant Trials Have Been Grading Every Medication Pass/Fail. A New Meta-Analysis Says That's Why None of Them Passed.

Cannabis Never Treated Your Anxiety — It Just Made Tonight Quieter